Medication info

Samchundang Ranitidine Tablets 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet (for export: opaque reddish-brown round film-coated tablet)
Packaging
100 tablets/box [(10 tablets/Alu-Alu × 10)]
Approval status
Expired

MFDS item code 199100965 · Notified 1991.10.19

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg per dose orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg of this drug per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this drug per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg of this drug per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For patients 12 years of age and older, administer 75 mg of this drug per dose orally twice daily (oral solution only). For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric ulcers due to NSAID use
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal erythema
  • gastric mucosal edema
  • acute gastritis
View approved original text

This medication is effective for various gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome before surgery and to treat gastric ulcers caused by NSAID use. Additionally, it helps improve gastric mucosal damage during acute and chronic gastritis exacerbations and aids in treating upper gastrointestinal bleeding. It is effective in alleviating symptoms of excessive gastric acid, heartburn, and acid regurgitation. Overall, this medication is used to protect the gastric mucosa and regulate gastric acid secretion to improve related symptoms.

How to take

Adult dose

(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg per dose orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg of this drug per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of 150 mg of this drug per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg of this drug per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For patients 12 years of age and older, administer 75 mg of this drug per dose orally twice daily (oral solution only). For ages 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in patients who have had hypersensitivity reactions to any of its components or a history of acute porphyria. Patients with poor kidney function may experience increased serum concentrations of this medication; therefore, they need to reduce the dosage or extend the dosing interval. Patients with compromised liver function should also use this medication with caution. Patients with a history of hypersensitivity reactions, elderly patients, and those taking non-steroidal anti-inflammatory drugs (NSAIDs) should be administered this medication carefully. In particular, patients with gastric ulcers or those over middle age with newly developed dyspeptic symptoms should check for gastric cancer before use. Patients with gastric or duodenal ulcers with Helicobacter pylori infection should undergo eradication therapy concurrently. This medication can rarely cause various side effects such as anaphylactic shock, hives, rash, blood abnormalities, liver function disorders, cardiac rhythm disturbances, gastrointestinal symptoms, neurological issues, musculoskeletal pain, skin rashes, etc., so if abnormal symptoms occur, immediate discontinuation and consultation with healthcare professionals are required. During treatment, regular blood tests and assessments of liver and kidney function should be conducted to check for abnormalities. Elderly patients and those with chronic lung diseases, diabetes, or weakened immune systems should be cautious as their risk of pneumonia may increase. If dizziness or drowsiness occurs after taking this medication, activities such as driving or operating dangerous machinery should be avoided. There may be potential interactions with other medications, especially anticoagulants or certain antibiotics; inform healthcare professionals when taking these medicines, and it may be necessary to adjust dosing intervals. Pregnant or breastfeeding women should carefully weigh the benefits and risks before using this medication. Safety in children has not been adequately established, so caution is needed. This medication is primarily excreted through the kidneys, so elderly patients should adjust doses considering reduced kidney function. It may affect urine protein test results, so caution should be applied in the testing methods. Overdose rarely presents special problems, but treatment such as vomiting or gastric lavage may be necessary. Keep out of reach of children, and avoid transferring to other containers.

Side effects

  • anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 58 more
  • leukopenia
  • thrombocytopenia
  • hypoplastic bone marrow
  • aplastic anemia
  • aplastic anemia
  • progressive anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movements
  • altered consciousness
  • liver-type muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a well-sealed container in a dry place at a temperature between 1 and 30 degrees Celsius. Proper storage allows the medication to maintain its effectiveness for a longer time.

Appearance and packaging

Appearance

White round film-coated tablet (for export: opaque reddish-brown round film-coated tablet)

Package unit

100 tablets/box [(10 tablets/Alu-Alu × 10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.